University Medical Center
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Meyer, Thomas
NCT05039099 / 2020-005971-11: A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Active, not recruiting
2
63
Europe, Canada, US, RoW
AP-101, Placebo
AL-S Pharma, AL-S Pharma
Amyotrophic Lateral Sclerosis
12/24
10/25
ID-ALS, NCT05852405: Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS

Completed
N/A
2000
Europe
Ambulanzpartner Soziotechnologie APST GmbH, Charite University, Berlin, Germany
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
12/24
12/24
NCT05852418: Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.

Recruiting
N/A
25000
Europe
Ambulanzpartner Soziotechnologie APST GmbH, Charite University, Berlin, Germany
Amyotrophic Lateral Sclerosis
12/28
06/29
Nauck, Friedemann
No trials found
Veiz, Elisabeth
No trials found
Reich, Günter
No trials found

Download Options